Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges

20 May 2024

Abstract excerpt

Breast cancer (BC) is the most frequent malignant cancer diagnosis and is a primary factor for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) positive, progesterone receptor (PR) positive, human epidermal growth factor receptor 2 (HER2) positive, and triple-negative BC (TNBC). Based on the stages and subtypes of BC, various treatment methods are available with variations in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HER2/EGFR in Cancer Research
Share to Histone Deacetylase Inhibitors Research
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38769556
DOI: 10.1186/s12943-024-02011-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challengesPMID 38769556Read ↗

Breast cancer genomic analyses reveal genes, mutations, and signaling networks.Semantic proximity Read ↗

DLGAP5 Regulates the Proliferation, Migration, Invasion, and Cell Cycle of Breast Cancer Cells via the JAK2/STAT3 Signaling AxisSemantic proximity Read ↗

Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast CancerSemantic proximity Read ↗

m5C related-regulator-mediated methylation modification patterns and prognostic significance in breast cancerSemantic proximity Read ↗

Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigmsSemantic proximity Read ↗

Signaling pathway dysregulation in breast cancer.Semantic proximity Read ↗

Comprehensive analysis of the NME gene family functions in breast cancerSemantic proximity Read ↗

WNT5B governs the phenotype of basal-like breast cancer by activating WNT signalingSemantic proximity Read ↗

Identification of novel biomarkers in breast cancer via integrated bioinformatics analysis and experimental validationSemantic proximity Read ↗

TET Enzymes and 5hmC Levels in Carcinogenesis and Progression of Breast Cancer: Potential Therapeutic TargetsSemantic proximity Read ↗

Systematic analysis of the expression and prognosis relevance of FBXO family reveals the significance of FBXO1 in human breast cancerSemantic proximity Read ↗

Immunohistochemical Profiling of Histone Modification Biomarkers Identifies Subtype-Specific Epigenetic Signatures and Potential Drug Targets in Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.